A clinical voice researcher reviewing a publication at a warm desk.
論文・資料

研究と方法論 Verbasyncより。

Amigo、回想録の作成、音声ベースのケア、臨床シグナル抽出、高齢者の関与に関する論文形式のホワイトペーパーと研究ノートをご覧いただけます。
すべてResearch hypothesisMethodology
注目の論文
Research white paper
Research-facing draft
AI-Guided Memoir Creation as a Reminiscence-Inspired Intervention for Older Adults
A hypothesis-driven research white paper on emotional engagement, self-worth, cognitive stimulation, and longitudinal monitoring
HTML記事を読む
Research hypothesis·May 2026·Version 0.1
Research white paper · Research-facing draft

AI-Guided Memoir Creation as a Reminiscence-Inspired Intervention for Older Adults

A hypothesis-driven research white paper on emotional engagement, self-worth, cognitive stimulation, and longitudinal monitoring

Alain Briez, Chief Executive Officer, Verbasync

This white paper proposes that AI-guided memoir creation, delivered through repeated natural voice conversations, may function as a scalable reminiscence-inspired model of emotional and cognitive engagement for older adults. The model is positioned as a testable research hypothesis, not a diagnostic or therapeutic claim.

Memoir creationReminiscence-inspired interventionOlder adultsSelf-worthCognitive stimulationLongitudinal speech monitoring
論文一覧

公開中の論文

3件の論文 · 最終更新 May 2026
Research white paper
Research-facing draft
AI-Guided Memoir Creation as a Reminiscence-Inspired Intervention for Older Adults
A hypothesis-driven research white paper on emotional engagement, self-worth, cognitive stimulation, and longitudinal monitoring
Research hypothesis·Research white paper·May 2026

AI-Guided Memoir Creation as a Reminiscence-Inspired Intervention for Older Adults

A hypothesis-driven research white paper on emotional engagement, self-worth, cognitive stimulation, and longitudinal monitoring

Alain Briez, Chief Executive Officer, Verbasync

This white paper proposes that AI-guided memoir creation, delivered through repeated natural voice conversations, may function as a scalable reminiscence-inspired model of emotional and cognitive engagement for older adults. The model is positioned as a testable research hypothesis, not a diagnostic or therapeutic claim.

Version 0.1HTMLで読む
Research white paper
Lab-facing draft
Naturalistic Daily Voice Sampling at Home for CNS Digital Biomarker Research
A hypothesis-driven research white paper on ecological validity, longitudinal measurement, and clinical trial data quality
Research hypothesis·Research white paper·May 2026

Naturalistic Daily Voice Sampling at Home for CNS Digital Biomarker Research

A hypothesis-driven research white paper on ecological validity, longitudinal measurement, and clinical trial data quality

Alain Briez, Chief Executive Officer, Verbasync

This white paper proposes that daily or high-frequency voice data collected through natural conversations in the participant home environment may provide complementary, ecologically valid, longitudinal data for CNS digital biomarker research. It positions home voice sampling as a hybrid layer alongside standardized clinic-based speech tasks, with validation requirements grounded in V3/V3+ digital measure methodology.

Version 1.0HTMLで読む
White paper
White Paper Series - Volume 1
From Conversational Data to Clinical Signal
A multi-dimensional framework for detecting affective distress in geriatric telephone companionship calls
Methodology·White paper·April 2026

From Conversational Data to Clinical Signal

A multi-dimensional framework for detecting affective distress in geriatric telephone companionship calls

Alain Briez, Chief Executive Officer & Head of Technology, Verbasync

Late-life depression remains among the most under-diagnosed health conditions in the developed world. This methodology paper describes how Verbasync transforms regular geriatric telephone companionship conversations into structured, clinically grounded signals anchored on GDS-15, GAD-7 and C-SSRS, with privacy-preserving outputs designed for professional caregivers and family members.

15ページHTMLで読む
研究協力について

方法論や検証ロードマップについて議論しませんか?

機関パートナーとの検証作業を継続しており、適格な臨床、運用、研究チームに対してブリーフィングを実施できます。